Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

19.38
Delayed Data
As of 3:59pm ET
 +0.23 / +1.20%
Today’s Change
15.15
Today|||52-Week Range
39.74
+16.26%
Year-to-Date
Myriad Genetics (MYGN) Launches EndoPredict Test in the US
Mar 14 / Zacks.com - Paid Partner Content
Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.
Mar 11 / MotleyFool.com - Paid Partner Content